German Pediatric Hemophilia Research Database

Recruiting

• Conditions: D66; D67; Hereditary factor VIII deficiency; Hemophilia A/B; Hereditary factor IX deficiency

• Registration Number: DRKS00011101
• Lead Sponsor: Dr. v. Haunersches KinderspitalKlinikum der Universität München

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-12-13
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

newly diagnosed Hem A or B, FVIII or FIX 0 - 25%

Exclusion Criteria

no consent

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Inhibitory antibodies against supplemented factor VIII / IX concentrate during the first 100 exposure days (laboratory value, Bethesda Units > 0.5 BU)

Secondary Outcome Measures

Name	Time	Method
Bleedings, Treatment Episodes, Joint health Score during the first 100 exposure days